[Clinical studies with a new beta receptor blocking agent from the indole series (LB 46)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001249:Asthma / Q000139:chemically induced; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D002196:Capillaries; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002302:Cardiac Output / Q000187:drug effects; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D002648:Child; D003864:Depression, Chemical; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced; D007211:Indoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000188:drug therapy; D011651:Pulmonary Artery; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D013771:Tetralogy of Fallot / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy
D007211:Indoles; D013565:Sympatholytics; D007545:Isoproterenol
Klinische Untersuchungen mit einem neuen Betarezeptorenblocker aus der Idolreihe (LB 46)